Effectiveness of salvage radiotherapy for superficial esophageal Cancer after non-curative endoscopic resection.
Aged
Aged, 80 and over
Esophageal Neoplasms
/ pathology
Esophageal Squamous Cell Carcinoma
/ pathology
Esophagoscopy
Female
Humans
Male
Middle Aged
Progression-Free Survival
Radiotherapy Planning, Computer-Assisted
/ methods
Radiotherapy, Adjuvant
/ methods
Retrospective Studies
Salvage Therapy
/ methods
Elective nodal irradiation
Endoscopic resection
Radiotherapy
Superficial esophageal cancer
Journal
Radiation oncology (London, England)
ISSN: 1748-717X
Titre abrégé: Radiat Oncol
Pays: England
ID NLM: 101265111
Informations de publication
Date de publication:
01 Jun 2020
01 Jun 2020
Historique:
received:
28
09
2019
accepted:
25
05
2020
entrez:
4
6
2020
pubmed:
4
6
2020
medline:
13
4
2021
Statut:
epublish
Résumé
Endoscopic resection is widely used as an effective treatment for superficial esophageal cancer. However, the risk of lymph node metastasis increases in cases of muscularis mucosae or deeper invasion, for which additional treatment such as radiotherapy or surgery is required. Accordingly, the current study investigated the efficacy and toxicity of salvage radiotherapy after non-curative endoscopic resection as an organ preservation strategy. We retrospectively reviewed 37 esophageal cancer patients who received salvage radiotherapy after non-curative endoscopic resection. The pathological invasion depths were the muscularis mucosae, submucosal layer, and muscularis propria in 14, 22, and one patient, respectively. All patients received external beam radiotherapy. Among them, eight received intraluminal brachytherapy following external beam radiotherapy. Elective nodal irradiation was administered to all patients. Twenty-five patients received concurrent platinum and fluorouracil-based chemotherapy. The median follow-up time was 74 months (range: 3-212). The 5-year progression-free survival and overall survival rates were 64 and 78%, respectively. No local or regional lymph node recurrence was observed. The causes of death included esophageal cancer in one patient, metachronous esophageal cancer in one patient, other malignancies in eight patients, and other causes in six patients. Late cardiac toxicities ≥ grade 3 were observed in six patients, one of whom died of arrhythmia. Salvage radiotherapy after non-curative esophageal endoscopic resection is an effective treatment as an organ preservation strategy. Although muscularis mucosae and submucosal cancer have a high risk of lymph node metastasis, our results suggest that elective nodal irradiation contributes to reduced regional node metastases.
Sections du résumé
BACKGROUND
BACKGROUND
Endoscopic resection is widely used as an effective treatment for superficial esophageal cancer. However, the risk of lymph node metastasis increases in cases of muscularis mucosae or deeper invasion, for which additional treatment such as radiotherapy or surgery is required. Accordingly, the current study investigated the efficacy and toxicity of salvage radiotherapy after non-curative endoscopic resection as an organ preservation strategy.
METHODS
METHODS
We retrospectively reviewed 37 esophageal cancer patients who received salvage radiotherapy after non-curative endoscopic resection. The pathological invasion depths were the muscularis mucosae, submucosal layer, and muscularis propria in 14, 22, and one patient, respectively. All patients received external beam radiotherapy. Among them, eight received intraluminal brachytherapy following external beam radiotherapy. Elective nodal irradiation was administered to all patients. Twenty-five patients received concurrent platinum and fluorouracil-based chemotherapy.
RESULTS
RESULTS
The median follow-up time was 74 months (range: 3-212). The 5-year progression-free survival and overall survival rates were 64 and 78%, respectively. No local or regional lymph node recurrence was observed. The causes of death included esophageal cancer in one patient, metachronous esophageal cancer in one patient, other malignancies in eight patients, and other causes in six patients. Late cardiac toxicities ≥ grade 3 were observed in six patients, one of whom died of arrhythmia.
CONCLUSIONS
CONCLUSIONS
Salvage radiotherapy after non-curative esophageal endoscopic resection is an effective treatment as an organ preservation strategy. Although muscularis mucosae and submucosal cancer have a high risk of lymph node metastasis, our results suggest that elective nodal irradiation contributes to reduced regional node metastases.
Identifiants
pubmed: 32487186
doi: 10.1186/s13014-020-01582-8
pii: 10.1186/s13014-020-01582-8
pmc: PMC7268314
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
133Références
Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):930-42
pubmed: 12605971
Dis Esophagus. 2000;13(2):125-9
pubmed: 14601903
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1078-85
pubmed: 22867894
Cancer. 2016 Mar 15;122(6):917-28
pubmed: 26716915
J Radiat Res. 2018 Sep 1;59(5):604-615
pubmed: 30085197
Endoscopy. 2014 Aug;46(8):640-4
pubmed: 24830402
Crit Rev Oncol Hematol. 2018 Apr;124:61-65
pubmed: 29548487
Ann N Y Acad Sci. 2018 Dec;1434(1):115-123
pubmed: 30138532
Gastrointest Endosc. 2003 Feb;57(2):165-9
pubmed: 12556777
Esophagus. 2018 Jul;15(3):127-152
pubmed: 29948477
J Clin Oncol. 2002 Mar 1;20(5):1167-74
pubmed: 11870157
Gastrointest Endosc. 2001 Aug;54(2):190-4
pubmed: 11474389
Int J Clin Oncol. 2015 Oct;20(5):897-904
pubmed: 25800809
Int J Clin Oncol. 2012 Jun;17(3):263-71
pubmed: 21748259
Ann Surg Oncol. 2012 Mar;19(3):750-6
pubmed: 21861216
Mod Pathol. 2006 Mar;19(3):475-80
pubmed: 16444191
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):667-676
pubmed: 29280461
Eur J Cardiothorac Surg. 2001 Dec;20(6):1089-94
pubmed: 11717009
Gastroenterology. 2019 Aug;157(2):382-390.e3
pubmed: 31014996
Ann Surg Oncol. 2011 Jun;18(6):1757-65
pubmed: 21207167
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):684-90
pubmed: 20932658
Am J Surg. 1997 Jul;174(1):49-53
pubmed: 9240952
Surgery. 1998 Apr;123(4):432-9
pubmed: 9551070
Diagn Ther Endosc. 1997;3(4):211-20
pubmed: 18493439
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002092
pubmed: 16437440
Cancer Med. 2016 Mar;5(3):506-15
pubmed: 26806272
Endoscopy. 2009 Apr;41(4):304-9
pubmed: 19340732
Endoscopy. 2006 Feb;38(2):149-56
pubmed: 16479422
Endoscopy. 2009 Aug;41(8):661-5
pubmed: 19565442
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1106-11
pubmed: 16504758
Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):147-51
pubmed: 21106566
Jpn J Clin Oncol. 2009 Oct;39(10):638-43
pubmed: 19549720